Eterna Therapeutics announced promising preclinical results for its lead cell therapy, ERNA-101, aimed at treating ovarian cancer by activating the immune system. In a study conducted at MD Anderson, ...
Skin cancer is the most common cancer in the U.S., according to the Centers for Disease Control and Prevention. Between 1982 and 2017, the rates of melanoma — which can be deadly when it spreads — ...
CAMBRIDGE, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (ERNA) (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced positive results ...
SEONGNAM, South Korea, Dec. 23, 2025 /PRNewswire/ -- SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback